Copyright
©The Author(s) 2023.
World J Clin Cases. Sep 26, 2023; 11(27): 6407-6414
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6407
Published online Sep 26, 2023. doi: 10.12998/wjcc.v11.i27.6407
Table 1 Comparison of general clinical data between the cancer group and the non-cancer group
Groups | Thyroid cancer group | Non-cancer group | P value |
Average age (yr) | 45.21 ± 8.35 | 45.63 ± 7.94 | > 0.05 |
Gender (Male/Female) | 25/35 | 30/40 |
Table 2 Comparison of serum thyroglobulin levels between the two groups
Group | Thyroid cancer group | Non-cancer group | t | P value |
Mean serum Tg level (ng/mL) | 10.24 ± 2.63 | 5.8 ± 1.91 | 1.863 | 0.013 |
Table 3 Comparison of serum thyroid-stimulating hormone levels between the two groups
Group | Thyroid cancer group | Non-cancer group | t | P value |
Mean serum TSH level (mIU/L) | 2.54 ± 0.83 | 2.3 ± 0.61 | 3.483 | 0.373 |
Table 4 Receiver operating characteristic test results
Area | Standard error | 95%CI | P value | |
0.898 | 0.028 | Lower limit | Upper limit | < 0.01 |
0.844 | 0.953 |
- Citation: Shuai JH, Leng ZF, Wang P, Ji YC. Correlation analysis of serum thyroglobulin, thyroid-stimulating hormone levels, and thyroid-cancer risk in thyroid nodule surgery. World J Clin Cases 2023; 11(27): 6407-6414
- URL: https://www.wjgnet.com/2307-8960/full/v11/i27/6407.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i27.6407